Importantly, with the treatment of leptin in these animals, there was the restoration of Pomc mRNA levels, underscoring the dynamic regulation of Pomc by leptin-induced changes in miRNAs, positioning them as potential therapeutic targets for metabolic disorders (76). This evidence concerns the gene LEP and metabolic disease.